Daily news

Using evidence as the guiding star, the @ducrest Twitter timeline consists of the latest scientific publications in dermatology, cosmetic dermatology, cosmetics and Home-Use devices. Here you will find interesting information gleaned from science and technology sources as well as the lay press.

« page 2

@drajay1 @TheJEADV Here it is
Cutaneous manifestations in COVID‐19: a first perspective


in reply to drajay1 — 5:25am Apr 7 2020 —

RT @juleslipoff: Our paper in @JAADjournals guiding dermatologists and all providers how to implement #telehealth in your clinics fast in a…

2:52am Apr 7 2020 —

RT @juleslipoff: New interview in @DermTimesNow on how telemedicine can help practices thrive during the COVID-19 crisis #telemedicine #COV…

2:52am Apr 7 2020 —

@drajay1 Thanks for your input. Literature is just starting, did you saw latest @TheJEADV article? #COVID19


in reply to drajay1 — 1:55am Apr 7 2020 —

@DermaSanMartin @eadv @TheJEADV @imcascongress @aedv_es @julianconejomir @SergioVanoG @Dr_A_Sadek @dranthonyrossi


in reply to DermaSanMartin — 1:32am Apr 7 2020 —

@DermatologyNews thanks for your post about the webinar

in reply to ducrest — 12:38am Apr 7 2020 —

COVID-19 and Clinical Dermatology: what does it change?
April 15th webinar. Dermatologists from 7 countries across…


12:21am Apr 7 2020 —

RT @ducrest: Adalimumab (THE $20 billion product) and the challenges for biosimilars – is the window closing for #biosimilars to have the l…

4:03pm Apr 6 2020 —

RT @ducrest: Addressing Bias in #ArtificialIntelligence in Health Care jamanetwork.com/journals/jama/… via @JAMA_current and about image classifica…

4:03pm Apr 6 2020 —

RT @NEJM: #VisualAbstract: Nemolizumab in Moderate-to-Severe Prurigo Nodularis. #Neurology #Dermatology

4:01pm Apr 6 2020 —